AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

AutoInflammatory Disease Alliance Registry (AIDA)

Recruitingn/aAges any - anyAllUniversity of Siena
💬

In plain words

What the trial is, and whether it could suit you

Autoinflammatory diseases (AID) are clinical entities characterized by recurrent inflammatory attacks in absence of infection, neoplasm or deregulation of the adaptive immune system. Among them, hereditary periodic syndromes, also known as monogenic AID, represent the prototype of this disease group, caused by mutations in genes involved in the regulation of innate immunity, inflammation and cell death. Based on recent experimental acquisitions in the field of monogenic AID, several immunologic disorders have been reclassified as polygenic/multifactorial AID, sharing pathogenetic and clinical features with hereditary periodic fevers. This has paved the way to new treatment targets for patients suffering from rare diseases of unknown origin, including Behçet's disease, Still disease, Schnitzler's disease, PFAPA (periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis) syndr

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * to be diagnosed with a monogenic AID according to the clinical phenotype and the detection of a confirmative genotype; * to be diagnosed with clinical familial Mediterranean fever or Behçet's disease or Still disease or PFAPA syndrome or Schnitzler's disease or CRMO according to the corresponding clinical diagnostic and/or classification criteria; * to be diagnosed with undifferentiated systemic AID; * to be diagnosed with non-infectious uveitis according to the standardization for uveitis nomenclature (SUN) criteria; * to be diagnosed with anterior or posterior non-infectious scleritis; * to be diagnosed with spondyloarthritis according to ASAS and/or New York criteria; * to be diagnosed with Castleman disease; Exclusion Criteria: \- informed consent/assent not provided by the patient and/or his/her legal representative.
💊

What it tests

  • No intervention is foreseen by the protocol.
📍

Where

112 sites
University Algiers 1
Algiers, Algeria
Université M'Hamed Bougara de Boumerdas
Boumerdas, Algeria
Flinders University
Adelaide, Australia
University of Adelaide
Adelaide, Australia
Antwerp University Hospital
Antwerp, Belgium
Hospital das Clinicas da Faculdade de Medicina HCFMUSP
São Paulo, Brazil
Peking University People's Hospital
Beijing, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China

…and 104 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy